Related Experiment Video
Updated: Jul 5, 2026
04:33
Methods for Detecting Cough and Airway Inflammation in Mice
Published on: August 2, 2024
Clinical pathways for chronic cough in children.
E J Bailey1, P S Morris, S G Kruske
1Menzies School of Health Research, Child Health Division, Darwin, Brisbane, Queensland, Australia. emily_bailey@health.qld.gov.au
The Cochrane Database of Systematic Reviews
|April 22, 2008
Summary
No studies met inclusion criteria for this review on clinical pathways for chronic cough in children. Further research is needed to determine if these pathways improve patient outcomes.
Area of Science:
- Pediatrics
- Respiratory Medicine
- Evidence-Based Medicine
Background:
- Chronic cough is a common and distressing symptom in children, impacting families and potentially indicating serious underlying conditions.
- Clinical guidelines can improve care, but specific pathways for pediatric chronic cough are needed due to age-related differences in causes and treatments.
- Evaluating the effectiveness of clinical pathways is crucial for optimizing the management of chronic cough in children.
Purpose of the Study:
- To systematically evaluate the effectiveness of utilizing a clinical pathway for managing children experiencing chronic cough.
Main Methods:
- A comprehensive literature search was conducted in May 2007 across multiple databases including CENTRAL, Cochrane Airways Group Register, MEDLINE, and EMBASE.
- Inclusion criteria focused on randomized controlled trials with parallel group designs comparing the use versus non-use of a clinical pathway for pediatric chronic cough.
- Two independent reviewers were planned for study selection and data extraction to ensure rigorous methodology.
Main Results:
- The search yielded 471 potentially relevant titles.
- However, no studies met the pre-defined inclusion criteria for this review.
Conclusions:
- Currently, there is insufficient evidence to recommend the use of clinical pathways for treating chronic cough in children.
- Individualized assessment of symptoms and signs is recommended for treatment and further investigation, considering existing evidence from other reviews.
- High-quality randomized controlled trials are necessary to establish the efficacy of clinical pathways in pediatric chronic cough management.
Related Concept Videos
01:24Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features
Chronic bronchitis is a key phenotype of chronic obstructive pulmonary disease (COPD), characterized by airway-centered inflammation and mucus overproduction. It develops from long-term exposure to harmful particles or gases, most commonly cigarette smoke, which triggers a persistent inflammatory response.Cellular and Structural ChangesInflammation initially affects the large bronchi and later the smaller airways, with infiltration by immune cells, including neutrophils, macrophages, and...
01:20Chronic Obstructive Pulmonary Disease-I: Introduction
Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
01:23Chronic Obstructive Pulmonary Disease I: Introduction
Chronic obstructive pulmonary disease is a common, preventable, and treatable respiratory disorder characterized by persistent symptoms and progressive airflow limitation. This limitation results from a combination of small-airway disease (obstructive bronchiolitis) and parenchymal destruction (emphysema), both driven by chronic inflammation from exposure to harmful particles or gases.The disease includes two main pathological entities: emphysema, marked by destruction of alveolar walls and...
01:24Chronic Obstructive Pulmonary Disease
COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
01:30Chronic Obstructive Pulmonary Disease-V: Nursing Management
Nursing management of Chronic Obstructive Pulmonary Disease (COPD) is crucial for providing thorough care and support to patients. Nurses play an integral role in this process through detailed assessment, careful planning, targeted interventions, and ongoing evaluation. Here's an overview of the critical steps in nursing management for COPD.
Assessment
Assessment
01:29Chronic Obstructive Pulmonary Disease-V: Management
Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
Smoking Cessation